Cargando…
Cancer Immunotherapy Trials Underutilize Immune Response Monitoring
Immune‐related radiological and biomarker monitoring in cancer immunotherapy trials permits interrogation of efficacy and reasons for therapeutic failure. We report the results from a cross‐sectional analysis of response monitoring in 685 T‐cell checkpoint‐targeted cancer immunotherapy trials in sol...
Autores principales: | Connell, Claire M., Raby, Sophie E.M., Beh, Ian, Flint, Thomas R., Williams, Edward H., Fearon, Douglas T., Jodrell, Duncan I., Janowitz, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AlphaMed Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759814/ https://www.ncbi.nlm.nih.gov/pubmed/29021379 http://dx.doi.org/10.1634/theoncologist.2017-0226 |
Ejemplares similares
-
Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes
por: Connell, C. M., et al.
Publicado: (2017) -
Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity
por: Flint, Thomas R., et al.
Publicado: (2016) -
Early relapse on adjuvant gemcitabine associated with an exceptional response to 2nd line capecitabine chemotherapy in a patient with pancreatic adenosquamous carcinoma with strong intra-tumoural expression of cytidine deaminase: a case report
por: Connell, Claire M., et al.
Publicado: (2020) -
Multicenter Validation of the CamGFR Model for Estimated Glomerular Filtration Rate
por: Williams, Edward H, et al.
Publicado: (2019) -
Clozapine is underutilized
por: Kane, John M.
Publicado: (2012)